U.S. Electrical Stock News

Agilent Technologies recently received European regulatory certification for its PD-L1 IHC 22C3 pharmDx test as a companion diagnostic in certain ovarian cancers, supporting identification of patients who may benefit from Merck’s Keytruda therapy. This cancer-specific approval enhances Agilent’s position in immuno-oncology diagnostics and deepens its collaboration with Merck, potentially broadening its clinical testing footprint across Europe. We’ll now explore how this new European ovarian...

The market rushed to reward Paramount Skydance, pushing the stock up about 4.5% to roughly $8.76, yet the real story is about an earnings engine still grinding through a long repair. Q2 2026 net income from ongoing operations stayed slim at about $41 million on revenue of roughly $6.9b, a small profit set against a trailing year that remains in the red. For a stock that has fallen over the past three months, this quarter reads less like a clean turnaround and more like the first credible...

loanDepot stock barely flinched after earnings, slipping just 0.9% to close near US$1, even though the headline story was a sharply smaller quarterly loss. Net loss narrowed to US$4.5m in Q2 on roughly US$295m of revenue, a marked improvement from the heavy red ink investors saw at the start of the year. The short term tape still looks bruised, with the share price down double digits over the past month. Yet the earnings call focused on a longer game, with management emphasizing rising gain...

Mercury General stock added 2.8% today to US$109.61, even though the real story sits in the insurer’s profit engine rather than the headline price pop. The key signal is margin. Trailing net profit margin sits at 13.7% compared with 5.1% a year earlier, and earnings over the past year are reported to be close to triple last year’s level. Investors cheering the move are reacting to a company that, on recent numbers, is earning more on each premium dollar while still trading on a single digit...

Alphatec Holdings just gave shareholders a jolt. The stock closed at US$9.57, down about 7.5% on the day, even though the headline from Q2 was clear. Revenue reached about US$214 million and adjusted earnings before interest, tax, depreciation and amortisation climbed to about US$36 million. Short term traders focused on the red on the screen. Longer term investors will likely be more interested in what this quarter says about Alphatec Holdings’ push toward higher margins, sustained double...

Fabrinet (FN) has drawn investor attention after recent share price swings, including a decline of about 2% in the latest session and a gain of roughly 26% over the past week. See our latest analysis for Fabrinet. The sharp 25.99% 7 day share price return for Fabrinet sits alongside a 30 day share price gain of 4.29% and a 90 day share price decline of 16.59%, while the 1 year total shareholder return of 57.08% and very large 5 year total shareholder return suggest momentum has built over the...

Select Water Solutions stock came into today on a strong run, with double digit gains over the past week and month, only to meet fresh Q2 numbers that put the focus squarely on earnings power. The headline is simple. Profit and revenue both sit solidly in the black, with Q2 net income of US$21.0 million on US$395.8 million of revenue, and basic EPS of roughly US$0.15. The bigger story for long term investors is the valuation strain. Select Water Solutions trades on a P/E that is far above...

The market rushed to reprice Assurant today. The stock jumped about 7% to roughly US$302, yet the bigger story sits inside the profit engine rather than the share chart. Assurant delivered record Q2 2026 results with adjusted earnings power that supported a higher full year outlook. For an insurer built around fee based protection services, the standout data point was strong adjusted earnings before interest, tax, depreciation and amortization growth in the mid to high teens, supported by...

In late July 2026, Charter Communications reported second-quarter 2026 results showing sales of US$13,526 million and net income of US$1,292 million, alongside active share repurchases totaling US$858.94 million for 3,996,545 shares and fresh debt market activity including a shelf registration and exchange offer for long-dated secured senior notes. An interesting aspect of these updates is that earnings per share from continuing operations increased year-on-year despite slightly lower sales...

Wynn Resorts stock jumped 3.6% to about US$101 in regular trading after its Q2 report, a sharp move for a company whose 90 day return has been under pressure. The market is reacting to one thing above all else: profitability is firming even as revenue holds near US$1.9b and net income from ongoing operations reaches roughly US$140m. That short term pop sits against a longer horizon where earnings have been growing over multiple years but face clear balance sheet risks. The headline today is...

The market marked Celanese down almost 5% today. Yet the headline from this earnings release is not collapse but compression. The stock sold off as investors fixated on the company’s still-weak trailing profit picture, even as quarterly earnings per share climbed back above US$1 and net income returned to a positive US$127m in Q2. For a chemicals producer that has been wrestling with losses and interest burdens, that profit squeeze and the struggle to cover financing costs remain the...

Healthy growth is hard to find when global data is so mixed, with some regions picking up speed and others cooling. A focused screener that looks for companies where analysts expect strong earnings growth over the next 3 years, while also checking that balance sheets are in acceptable shape, can help you cut through the noise. The Healthy high growth potential screener does exactly that. In this article you will see 3 stocks from this universe that stand out on growth quality and financial...

PACS Group stock closed up 1.9% at US$45.64 after its latest report, a measured move for a company that just reported another quarter of stronger earnings. Net income reached US$76.4 million on US$1.43b of revenue, resulting in a trailing net margin of 4.8% that now sits well above last year’s level. The short-term reaction is modest. The bigger story is that investors now have to weigh that improving profitability against a P/E of 26.8x, along with multi-year earnings growth forecasts that...

WeRide (WRD) stock is back in focus after the company announced a partnership with GreenMobility to roll out Level 4 autonomous shared mobility services in Denmark, marking its first entry into the Nordic region. See our latest analysis for WeRide. The GreenMobility agreement comes after a tough period for WeRide shareholders, with the year to date share price return down 36.32% and the 1 year total shareholder return down 31.03%. However, recent 7 day and 30 day share price returns of 3.46%...

Lattice Semiconductor shareholders woke up to a sentiment shock. The stock dropped about 7% to US$128.31 on the first trading day after earnings, even as the company posted record Q2 revenue of US$201.1m and strong earnings per share of US$0.14 on a basic basis and US$0.53 on a non generally accepted accounting principles basis. The market is treating the print as a problem. The numbers read more like a stress test in a stock that was already priced for perfection. Impressed by Lattice...

Interparfums stock gave up 4% today, which looks more like a mood swing than a verdict on the business. The fragrance group just posted Q2 revenue of US$341.0m with basic earnings per share of US$0.95. These numbers sit in the context of a trailing twelve month basic earnings per share figure of US$5.23. The key issue is margin pressure. Operating profitability for the first half of 2026 has softened, even as tariff refunds and strong brands help cushion the impact. That is what today’s price...

Bio-Rad Laboratories stock jumped about 4.5% in regular trading, which indicates that traders responded positively to the latest results. The bigger story is less about a one-day move and more about whether this quarter marks a cleaner earnings run rate after a very choppy year. Q2 revenue was US$651 million and non-GAAP earnings per share were US$2.62, roughly in line with the same period last year. For long-term holders, the key question is how this steadier quarter fits with modest growth...

TransDigm Group’s stock slipped about 1.6% today, yet the quarterly story investors just saw was about profit power holding firm despite a heavy balance sheet. Q3 revenue reached US$2.741b with net income of US$539m, keeping basic earnings per share near double digits at US$9.39. Those profits sit on top of roughly US$33.7b of gross debt and interest coverage of about 3x, which keeps leverage in focus. For a stock that had cooled a bit over the past month, this earnings report highlights how...

Adaptive Biotechnologies stock barely budged after earnings, closing up just 0.2% around US$24.61. That muted move sits awkwardly against a quarter that put its core cancer minimal residual disease diagnostics front and center. Total revenue reached US$71.6m, while the company reported a net loss of US$39.8m that was heavily influenced by debt extinguishment and interest tied to the OrbiMed agreement. The key takeaway for investors is margin and profit pressure alongside a strong MRD growth...

DaVita stock just endured a 17% single day drop, yet the earnings story that triggered it looks far more measured. The company delivered adjusted earnings per share of US$4.02 in the quarter and reaffirmed full year adjusted earnings guidance around US$14.65. For a healthcare services stock that closed yesterday near US$228 and now trades around US$189, this is a sentiment shock focused less on an earnings miss and more on worries about long term margins and debt. Is DaVita suddenly a 48% off...

Westlake stock slipped about 2% today, even though the quarter finally put real profits back on the table. You are looking at a chemicals producer that just swung from a string of quarterly losses to Q2 net income of US$260 million on revenue of US$3.3b. That break in the loss pattern is the headline. The short term price move reflects nerves about how durable this earnings step change might be. The bigger story is whether this profit rebuild can hold over the coming years as management...

Entegris stock barely flinched after earnings, up just 0.8% to US$145.75, yet the report itself was anything but muted. The market treated it as just another decent quarter. The numbers pointed to something more important for a high multiple semiconductor supplier. The real story was margin power. Revenue landed at US$883.2m with adjusted gross margin at 47.6%, the strongest level since early 2022, and adjusted EBITDA margin at 28.4%. For a stock trading on a rich trailing P/E of 72.8x, that...

Navigator Holdings came into this print with a stock that had cooled off in the near term and sat roughly flat over the past month, yet the market still knocked the shares down about 4% to US$20.57 on the day. That reaction sits awkwardly against what was just reported. Q2 delivered record net income of US$53.0m and record earnings per share of US$0.86, powered by very strong time charter equivalent rates and utilization across its liquefied gas fleet. The tension for investors now is clear...

Cognex (NASDAQ: CGNX), a machine vision technology company, recently reported quarterly results after market hours, following a period in which it previously exceeded analysts’ revenue and EPS expectations and issued revenue guidance above forecasts. With the market now expecting meaningful year-on-year revenue growth, investor attention has intensified on whether Cognex can sustain its recent operational momentum and outlook. With investors focused on Cognex’s prior earnings beat and...